The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Open accessAbstract
During persistent antigen stimulation, CD8(+) T cells show a gradual decrease in effector function, referred to as exhaustion, which impairs responses in the setting of tumors and infections. Here we demonstrate that the transcription factor NFAT controls the program of T cell exhaustion. When expressed in cells, an engineered form of NFAT1 unable to interact with AP-1 transcription factors diminished T cell receptor (TCR) signaling, increased the expression of inhibitory cell surface receptors, and interfered with the ability of CD8(+) T cells to protect against Listeria infection and attenuate tumor growth in vivo. We defined the genomic regions occupied by endogenous and engineered NFAT1 in primary CD8(+) T cells and showed that genes directly induced by the engineered NFAT1 overlapped with genes expressed in exhausted CD8(+) T cells in vivo. Our data show that NFAT promotes T cell anergy and exhaustion by binding at sites that do not require cooperation with AP-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exhausted cells presented a high activity of Nfatc1 regulon, which is presumably involved in regulating the exhaustion process (50–53).”
From Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes (2019) · cites this paper as [51]
In the citing paper
“TCR-induced Ca2+–NFAT signaling is indispensable for T cell exhaustion and induces the expression of inhibitory surface receptors, such as PD-1, Lag-3 and Tim-3 (ref. 43).”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 1×
“Barcoded librarieswere sequenced in aSOLID4 sequencer (Applied Biosystems) and the reads were mapped by Bowtie (Langmead et al., 2009) to the mm9 genome in color-space.”
Calcium's Role in Mechanotransduction during Muscle Development
Damm, T. B., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,552
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,682
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 15×
“, 2011), and in CD8 T cells in the context of prolonged low-grade antigenic stimulation and/or inflammation, as encountered in chronic viral infections and cancer (Schietinger and Greenberg, 2014; Wherry, 2011).”
InfluentialRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057 · cited 4×
“, 2006), and blocking this pathway during chronic LCMV infection reinvigorates virus-specific CD8 T cell responses, resulting in lower viral loads (Barber et al., 2006).”
InfluentialTRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C. H., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,592 · cited 2×
“Notably, most NFAT1 ChIP-seq peaks did not overlap with CARIT-NFAT1 ChIP-seq peaks (Figure 4A, left and middle), suggesting that at these sites, NFAT binding is strongly stabilized by AP-1 (probably by 20-fold ormore) (Rao et al., 1997).”
Self-citationMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103 · cited 14×
“…in CD8+ and CD4+ T cells by CA-RIT-NFAT1 and those observed in exhausted CD8+ T cells and anergic CD4+ T cells in vivo (22/56 genes and 99/371 genes, respectively; p value < 10 10) (Figures 2E, 2F, and S3E; Tables 1, S1, and S2; Doering et al., 2012; Okamura et al., 2009; Wherry et al., 2007).”
InfluentialTargeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072 · cited 2×
“Moreover, antibodies to PD-1 and CTLA-4 have emerged as surprisingly effective agents for cancer immunotherapy (Schietinger and Greenberg, 2014), and individual or combined blockade of TIM3, PD-1, and LAG3 with antagonist antibodies has been shown to reverse exhaustion efficiently in CD8 T cells (Blackburn et al., 200…”
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062 · cited 2×
“Moreover, antibodies to PD-1 and CTLA-4 have emerged as surprisingly effective agents for cancer immunotherapy (Schietinger and Greenberg, 2014), and individual or combined blockade of TIM3, PD-1, and LAG3 with antagonist antibodies has been shown to reverse exhaustion efficiently in CD8 T cells (Blackburn et al., 200…”
Transcriptional regulation by calcium, calcineurin, and NFAT
Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes & Development · doi:10.1101/gad.1102703 · Cited by 1,991 · cited 3×
“The ability to participate inmultiple transcriptional complexes allows NFAT to contribute to different transcriptional programs depending on the cell type and signaling context in which it is activated (Hogan et al., 2003).”
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 866
Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
Viganó, S., Bobisse, S., Coukos, G., Perreau, M., & Harari, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01350 · Cited by 21
Prasad, M., Brzostek, J., Gautam, N., Balyan, R., Rybakin, V., & Gascoigne, N. R. J. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00578-4 · Cited by 24
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity
Copland, A., Mackie, G. M., Scarfe, L., Jinks, E., Lecky, D. A. J., Gudgeon, N. H., McQuade, R., Ono, M., Barthel, M., Hardt, W., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00159-2 · Cited by 19
“Downstream of proximal phosphorylation events at the TCR complex is the fl ux of calcium that leads to NFAT translocation into the nucleus; Nr4a3 has been established as a calcium/NFAT-dependent gene (Jennings et al, 2020), and therefore this was investigated.”
InfluentialPeng, Z., Nagarajan, V., Horai, R., Jittayasothorn, Y., Mattapallil, M. J., & Caspi, R. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115780 · Cited by 20
“57,67 Moreover, we noticed the presence of regulons for the nuclear receptors for RA, Rara and Rxra.”
T cell adaptation in chronic infections and tumors
Luxenburger, H., Thimme, R., & Hofmann, M. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01405-y · Cited by 20
“Sustained TCR engagement activates the calcineurin – NFAT pathway, and in the context of chronic stimulation, NFAT is translocated to the nucleus largely without AP-1, directly driving the transcription of Nr4a genes [51, 54].”
Jayashankar, L., & Hafner, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00577 · Cited by 20
“During persistent antigen stimulation, NFAT promotes T cell exhaustion by binding directly to regulatory regions of PD-1 and TIM3 (68).”
BackgroundInfluentialBATF represses BIM to sustain tolerant T cells in the periphery
Titcombe, P. J., Morales, M. S., Zhang, N., & Mueller, D. L. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230183 · Cited by 19
“…AP-1 site occupant furthermore reconciles these data with the historical notion that T cell anergy lacks AP-1 recruitment (Mondino et al., 1996; Maci´an et al., 2002; Maci´an, 2005; Fathman and Lineberry, 2007; Martinez et al., 2015), as most earlier studies would not have directly probed for BATF.”
BackgroundCheng, Y., Shao, Z., Chen, L., Zheng, Q., Zhang, Q., Ding, W., Zhang, M., Yu, Q., & Gao, D. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.11.004 · Cited by 20
How Can We Engineer CAR T Cells to Overcome Resistance?
Glover, M., Avraamides, S., & Maher, J. F. (2021) · Biologics · doi:10.2147/btt.s252568 · Cited by 19
“which is likely the mechanism of improved function when CAR T cells are engineered to overexpress c-Jun.(97,98)”
BackgroundImmunosuppressive Signaling Pathways as Targeted Cancer Therapies
Damane, B. P., Hull, R., Bida, M., Durandt, C., Mulaudzi, T. V., Chatziioannou, A. A., & Dlamini, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10030682 · Cited by 20
Marshall, N., Hutchinson, K., Marron, T. U., Aleynick, M., Hammerich, L., Upadhyay, R., Svensson‐Arvelund, J., Brown, B. D., Mérad, M., & Brody, J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0391 · Cited by 19
Weber, E. W., Lynn, R. C., Parker, K. R., Anbunathan, H., Lattin, J., Sotillo, E., Good, Z., Malipatlolla, M., Xu, P., Vandris, P., et al. (2020) · doi:10.1101/2020.01.26.920496 · Cited by 18
“12 AP-1 family TF motifs (BATF, BATF3, JUNB, NFATC2), which are known to promote T cell exhaustion (Kurachi et al., 2014; Lynn et al., 2019; Man et al., 2017; Martinez et al., 2015; Scott-Browne et al., 2016), were highly enriched in accessible regions of the Always ON epigenome, but rendered less accessible following…”
BackgroundIRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression
Hirsch, T., Neyens, D., Duhamel, C., Bayard, A., Vanhaver, C., Luyckx, M., de Oyanguren, F. S., Wildmann, C., Dauguet, N., Squifflet, J.-L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114401 · Cited by 20
Heidari‐Foroozan, M., Rezalotfi, A., & Rezaei, N. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2401352 · Cited by 19
“Paradoxically, NFAT is also associated with T cell exhaustion [123,124].”
Immune checkpoint blockade for cancer therapy: current progress and perspectives
Ye, H., Liao, W., Pan, J., Shi, Y. P., & Wang, Q. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300492 · Cited by 23
“In macrophages, PD-1 expression is upregulated by Toll-like receptor (TLR)-induced NF-κ B activation (Bally et al., 2015; Martinez et al., 2015; Voron et al., 2015).”
Pan, Q., Ding, L., Hladyshau, S., Yao, X., Zhou, J., Yan, L., Dhungana, Y., Shi, H., Qian, C., Dong, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59620-6 · Cited by 24
Yoshimura, A., Aki, D., & Ito, M. (2021) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.97.016 · Cited by 19
Resistance and recurrence of malignancies after CAR-T cell therapy
Zeng, W., & Zhang, P. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112971 · Cited by 18
Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review
Mishra, K. P., Singh, M., Saraswat, D., Ganju, L., & Varshney, R. K. (2022) · Viral Immunology · doi:10.1089/vim.2022.0002 · Cited by 19
“An example of transcriptional regulation of T cell exhaustion involves the transcription factor NFAT, which in the absence of co-stimulatory protein AP-1 induces the state of T cell exhaustion in both CD8 + and CD4 + T cells (22).”
The TOX subfamily: all-round players in the immune system
Han, J., Wan, M., Ma, Z., & He, P. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac037 · Cited by 18
Application of ATAC-seq in tumor-specific T cell exhaustion
Chen, C., Liu, J., Chen, Y., Lin, A., Mou, W., Zhu, L., Yang, T., Cheng, Q., Zhang, J., & Luo, P. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00495-w · Cited by 19
“For acute immune responses, NFAT mainly coordinated with its transcription factor partner activator protein-1 (AP-1) to induce effector T cells [38, 63].”
BackgroundMethodResultIntracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function
Collier, C., Wucherer, K., McWhorter, M., Jenkins, C., Bartlett, A. Q., Roychoudhuri, R., & Eil, R. L. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0319 · Cited by 17
Mishra, H., Kesharwani, R. K., Singh, D. B., Tripathi, S., Dubey, S. K., & Misra, K. (2019) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-018-0177-x · Cited by 18
Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies
Shen, C., Zhang, Z., & Zhang, Y. (2020) · BioMed Research International · doi:10.1155/2020/8765028 · Cited by 18
Self-citationArranz‐Nicolás, J., Martin-Salgado, M., Rodríguez‐Rodríguez, C., Liébana, R., Moreno-Ortíz, M. C., Leitner, J. M., Steinberger, P., Ávila‐Flores, A., & Mérida, I. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001521 · Cited by 17
NHA2 promotes cyst development in an in vitro model of polycystic kidney disease
Prasad, H., Dang, D. K., Kondapalli, K. C., Natarajan, N., Cebotaru, V., & Rao, R. (2018) · The Journal of Physiology · doi:10.1113/jp276796 · Cited by 18
“2B-D), and evidence from the literature showing significant up-regulation of NHA2 upon ectopic expression of engineered constitutively active NFAT1 in T cells (34).”
BackgroundWang, G., Yu‐Zhu, W., Yu, Y., Feng, S., Fu, X.-L., & Heng, Z. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29243 · Cited by 17
Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer
Li, S., Hao, L., Zhang, J., Deng, J., & Hu, X. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00785-x · Cited by 17
Antigen perception in T cells by long-term Erk and NFAT signaling dynamics
Wither, M. J., White, W. L., Pendyala, S., Leanza, P. J., Fowler, D. M., & Kueh, H. Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308366120 · Cited by 17
“At the same time, NFAT can work independently from AP - 1, a mode of regulation for exhaustion - or anergy - associated genes (e.g., Pdcd1 ) (53, 56–58).”
Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity
Sabag, B., Puthenveetil, A., Levy, M., Joseph, N., Doniger, T., Yaron, O., Karako‐Lampert, S., Lazar, I., Awwad, F., Ashkenazi, S., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00094-5 · Cited by 18
“In addition, we explored whether the anergic NK gene pro fi le overlapped with the canonical “ CD8 + T-cell exhaustion ” program by obtaining gene sets from Martinez et al (NFAT signature) (Martinez et al, 2015a) Figure 1.”
BackgroundShukla, S., Kumari, S., Bal, S. K., Mónaco, D. C., Ribeiro, S. P., Sékaly, R., & Sharma, A. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000692 · Cited by 17
“However, under chronic antigen stimulation, NFAT promotes exhaustion by inducing expression of ICIs like PD1, TIM3, TIGIT, CTLA4 and lowered secretion of IL-2, TNF-a, IFN-g, and Granzyme B in effector T cells [59].”
BackgroundAmes, R. Y., Ting, L.-M., Gendlina, I., Kim, K., & Macian, F. (2017) · Infection and Immunity · doi:10.1128/iai.00364-17 · Cited by 16
Deciphering the role of histone modifications in memory and exhausted CD8 T cells
Huang, H., Baxter, A. E., Zhang, Z., Good, C. R., Alexander, K. A., Chen, Z., Garcia, P. A. A., Samareh, P., Collins, S. M., Glastad, K. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-99804-0 · Cited by 16
Liu, H., & Liang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1616794 · Cited by 19
BACH2 regulates T cell lineage state to enhance CAR T cell function
Chang, T.-C., Heard, A. D., Lattin, J., Warrington, J. M., Barrett, A., Landmann, J. H., Tenzin, Y., Ganesh, V., Thompson, B., Afrin, S. A., et al. (2026) · Nature Immunology · doi:10.1038/s41590-025-02391-5 · Cited by 17
“S demonstrated high activity of NFAT and AP-1, T cell activating factors that, when dysregulated or active for prolonged periods, can drive T cell exhaustion 3,15 (Extended Data Fig.”
Yu, L., Guan, Y., Li, L., Lü, N., & Zhang, C. (2022) · FEBS Journal · doi:10.1111/febs.16342 · Cited by 20
Watanabe, M., Motooka, D., & Yamasaki, S. (2023) · Science Signaling · doi:10.1126/scisignal.abn9909 · Cited by 16
Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
Li, F., Wang, Y. J., Chen, D., & Du, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031396 · Cited by 17
Participation of T cells in generating immune protection against cancers
Deo, A. S., Shrijana, Sruthika, S. U., Karun, S., Bisaria, K., & Sarkar, K. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155534 · Cited by 18
Role of T Lymphocytes in Glioma Immune Microenvironment: Two Sides of a Coin
Noor, L., Upadhyay, A., & Joshi, V. (2024) · Biology · doi:10.3390/biology13100846 · Cited by 16
Wang, J., Liu, J., Tian, F., Zhan, Y., & Kong, D. (2019) · Oncology Letters · doi:10.3892/ol.2019.10970 · Cited by 16
Wang, G., Tajima, M., Honjo, T., & Ohta, A. (2021) · International Immunology · doi:10.1093/intimm/dxab059 · Cited by 18
Barili, V., Vecchi, A. L., Rossi, M., Montali, I., Tiezzi, C., Penna, A., Laccabue, D., Missale, G., Fisicaro, P., & Boni, C. (2021) · Cells · doi:10.3390/cells10102563 · Cited by 18
Czerwińska, P., Ruciński, M., Wlodarczyk, N. A., Jaworska, A. M., Grządzielewska, I., Gryska, K., Galus, Ł., Mackiewicz, J., & Mackiewicz, A. A. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1710063 · Cited by 15
Nardini, E., Rodríguez, E., & van Kooyk, Y. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101913 · Cited by 15
Rotnemer-Golinkin, D., & Ilan, Y. (2022) · Pharmacology · doi:10.1159/000524747 · Cited by 15
Mitochondria Dictate Function and Fate of HSCs and T Cells
Xu, Y., Chiang, Y.-H., Ho, P., & Vannini, N. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0685 · Cited by 16
LKB1 prevents ILC2 exhaustion to enhance antitumor immunity
Niu, H., Zhang, H., Wang, D., Zhao, L., Zhang, Y., Zhou, W., Zhang, J., Su, X., Sun, J., Su, B., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113579 · Cited by 15
Self-citationRIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity
Duan, X., Hu, J., Zhang, Y., Zhao, X., Yang, M., Sun, T., Liu, S., Chen, X., Feng, J., Li, W., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00136-9 · Cited by 15
“…requiring further investigation, possibly due to the loss of KLHL22 leading to reduced RIG-I degradation (Zhou et al, 2020), or regulated by the NFAT transcription factor family in the process of CD8 + T-cell exhaustion that leads to RIG-I upregulation (Martinez et al, 2015; Tillé et al, 2023).”
Self-citationCooperation of RNA-Binding Proteins – a Focus on Roquin Function in T Cells
Behrens, G., & Heissmeyer, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839762 · Cited by 15
Self-citationMélique, S., Yang, C., & Lesourne, R. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.03.008 · Cited by 16
“[62] Martinez GJ, Pereira RM, Aijo T, Kim EY, Marangoni F, Pipkin ME, et al.”
BackgroundCholinergic T cells revitalize the tumor immune microenvironment: TIME to ChAT
Zheng, C., Liu, S., Modares, N. F., Paul, M. S., & Mak, T. W. (2025) · Nature Immunology · doi:10.1038/s41590-025-02144-4 · Cited by 16
“When uncoupled from AP-1, NFAT proteins trigger a negative regulatory program that suppresses the immune response 99 .”
Guo, R., Wang, R., Zhang, W., Li, Y., Wang, Y., Wang, H., Li, X., & Song, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5554 · Cited by 14
“In endothelial cells, NFAT is essential in the specific induction of EGR3 expression by VEGF, while EGR3 further enhances dScR‑1 expression in VEGF‑treated endothelial cells, establishing a self‑limiting regulatory circuit that preserves the dynamic balance of the pathway by inhibiting NFAT‑dependent EGR3 activation t…”
InfluentialLi, Y., & Wang, L. (2026) · Immunology · doi:10.1111/imm.70103 · Cited by 18
Aoki, T., Nishida, N., & Kudo, M. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211056853 · Cited by 15
Quantitative contributions of TNF receptor superfamily members to CD8+ T‐cell responses
Nguyen, J., Pettmann, J., Krüger, P., & Dushek, O. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110560 · Cited by 14
“…of transcription factors in favour of NFAT is also implicated in the induction of these states (Maci (cid:1) an et al , 2002; Wells, 2009; Martinez et al , 2015), so it is not surprising that TNFRSF co-stimulation has been reported to counter-act both anergy and exhaustion in vivo…”
Tian, W., Qin, G., Jia, M., Li, W., Cai, W., Wang, H., Zhao, Y., Bao, X., Wei, W., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198551 · Cited by 16
Self-citationXiao, Z., Wang, S., Chen, J., Li, Y., Jiang, Y., Tin, V. P., Liu, J. S., Hu, H., Wong, M. P., Pan, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202306059 · Cited by 14
Hadiloo, K., Taremi, S., Safa, S. H., Amidifar, S., & Esmaeilzadeh, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107158 · Cited by 14
Smith, A. L., Skupa, S. A., Eiken, A. P., Reznicek, T. E., Schmitz, E. G., Williams, N., Moore, D. Y., D'Angelo, C. R., Kallam, A., Lunning, M. A., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.177054 · Cited by 14
“…treatment also included those associated with immune activation (Stat, IRF, and RHD families) (62–65) as well as those present in more differentiated cells (retinoic acid receptors DR5 motif) (66) and binding motifs for TFs that can cooperate to drive T cell exhaustion (NFAT, BATF, IRF4) (65, 67).”
BackgroundHsu, L., Rosenbaum, J. T., Verner, E. J., Jones, W. B., Hill, C. M., Janc, J. W., Buggy, J. J., Pawar, R. D., Ghosh, P., Li, D., et al. (2024) · npj Drug Discovery. · doi:10.1038/s44386-024-00002-1 · Cited by 12
A key control point in the T cell response to chronic infection and neoplasia: FOXO1
Marcel, N., & Hedrick, S. Μ. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.02.001 · Cited by 16
Morianos, I., Tsitsopoulou, A., Potaris, Κ., Valakos, D., Fari, O., Vatsellas, G., Bostantzoglou, C., Photiades, A., Gaga, M., Xanthou, G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02092-5 · Cited by 15
LARP4-mediated hypertranslation drives T cell dysfunction in tumors
Liu, Y., Ni, H., Li, J., Yang, J., Sekielyk, I., Snow, B. E., Zhang, Z., Zhang, F., Paul, M. S., Han, J., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02232-5 · Cited by 18
Self-citationGzmk+ CD8 T cells in inflammatory diseases
Cui, X., Liu, P., Zhan, Q., & Cao, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661755 · Cited by 16
Heyden, L., Rausch, L., Shannon, M. H., Dryburgh, L., Moreira, M. L., Frolov, A., Scheffler, C. M., van Elsas, M. J., Tong, J., Hidajat, O., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02316-2 · Cited by 14
“T cell exhaustion is driven by persistent antigen exposure, which leads to the high and persistent expression of T cell antigen receptor (TCR)-signaling-induced transcription factors, such as NFATC1, IRF4, BATF, NR4A and TOX 3–5 , 10–16 .”
Studstill, C. J., & Hahm, B. (2021) · Viruses · doi:10.3390/v13101951 · Cited by 15
“As a result, NFAT-deficient mice were shown to have fewer virus-specific CD8+ T cells expressing PD-1, Tim-3, and LAG-3 during LCMV infection [113,114].”
BackgroundPut in a “Ca2+ll” to Acute Myeloid Leukemia
Lewuillon, C., Laguillaumie, M.-O., Quesnel, B., Idziorek, T., Touil, Y. S., & Lemonnier, L. (2022) · Cells · doi:10.3390/cells11030543 · Cited by 16
Bal, S. K., Giuliani, S., Block, J., Repiščák, P., Hafemeister, C., Shahin, T., Kasap, N., Ransmayr, B., Miao, Y., van de Wetering, C., et al. (2023) · Blood · doi:10.1182/blood.2022018303 · Cited by 17
Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1− Dysfunctional State
Roetman, J. J., Erwin, M. M., Rudloff, M. W., Favret, N. R., Román, C. R. D., Apostolova, M. K. I., Murray, K. A., Lee, T., Lee, Y. A., & Philip, M. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0939 · Cited by 13
Nielsen, H. V., Yang, L., Mueller, J. L., Ritter, A. J., Hiwa, R., Proekt, I., Rackaityte, E., Aylard, D. A., Gupta, M., Scharer, C. D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55839-5 · Cited by 12
“Anjana Rao and colleagues showed that a constitutively active form of NFAT that cannot cooperate with AP-1 (CA-NFAT-RIT) drives an anergic transcriptional program 72 .”
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity
Waugh, K. A., Leach, S. M., & Slansky, J. E. (2015) · Vaccines · doi:10.3390/vaccines3030771 · Cited by 14
“NFAT1 mutant incapable of binding AP-1 decreases TCR signaling and promotes exhaustion to result in uncontrolled infection and tumor growth [151].”
BackgroundPan, B., Wang, Z., Yao, Y., Ke, X., Shen, S., Chen, W., Zhang, X., Qiu, J., Wu, X., & Tang, N. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00830-9 · Cited by 13
Beltra, J., Abdel-Hakeem, M. S., Manne, S., Zhang, Z., Huang, H., Kurachi, M., Su, L., Picton, L. K., Muroyama, Y., Casella, V., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.03.509766 · Cited by 13
CD8+ T cell stressors converge on shared metabolic–epigenetic networks
Shangguan, Y., Wang, J., Ho, P., & Xu, Y. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.08.009 · Cited by 14
Yin, P., Yang, J.-G., Jiang, Y., Han, L., Xiong, T.-C., Liu, H., Fang, Y., Ruan, W., Wu, J., Chen, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw3571 · Cited by 13
“…showed that NR4A3 KD CAR T cells during CAE displayed up-regulation of several AP-1 (bZIP) family members, including JUNB, JUND, BATF, and BATF3, which have been reported to drive an effector phenotype in T cells, enabling them to secrete large amounts of effector cytokines in tumors ( 30 , 32 ).”
CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead
Shaer, N. S. H. A., Masoud, I., Tleyjeh, A., Al-Attas, A. A., Al-Attas, M. A., Khan, M. I., & Yaqinuddin, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1796675 · Cited by 15
“A central driver of this state is the NFAT family; under conditions of chronic stimulation, NFAT shifts from forming cooperative heterodimers with AP-1 to forming homodimers, which directly promote the expression of inhibitory receptors such as PD-1, LAG-3, and TIM-3 (93 – 95).”
Mohammadpour, H., Tsuji, T., MacDonald, C. R., Sarow, J. L., Rosenheck, H. R., Daneshmandi, S., Choi, J. E., Qiu, J., Matsuzaki, J., Witkiewicz, A. K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112250 · Cited by 12
Sun, Y., Tao, Y., Geng, Z., Zheng, F., Wang, Y., Wang, Y., Fu, S., Wang, W., Xie, C., Zhang, Y., et al. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156304 · Cited by 12
Self-citationCo-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
Khopanlert, W., Choochuen, P., Maneechai, K., Jangphattananont, N., Ung, S., Okuno, S., Steinberger, P., Leitner, J. M., Sangkhathat, S., Viboonjuntra, P., et al. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200837 · Cited by 12
Zhi, L., Su, X., Yin, M., Zhang, Z., Lü, H., Niu, Z., Guo, C., Zhu, W., & Zhang, X. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104436 · Cited by 13
Silencing and activating anergic B cells*
Tanaka, S., Ise, W., Baba, Y., & Kurosaki, T. (2021) · Immunological Reviews · doi:10.1111/imr.13053 · Cited by 12
The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
Hassanian, H., Asadzadeh, Z., Baghbanzadeh, A., Derakhshani, A., Dufour, A., Khosroshahi, N. R., Najafi, S., Brunetti, O., Silvestris, N., & Baradaran, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938063 · Cited by 12
“Exhausted CD8+ T cells do not proliferate well because they have impaired killing activity and secrete Low levels of effector cytokines such as INF-g and TNF-a (45).”
BackgroundSandu, I., & Oxenius, A. (2023) · Immunological Reviews · doi:10.1111/imr.13203 · Cited by 14
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor
Lainšček, D., Golob-Urbanc, A., Mikolič, V., Pantović-Žalig, J., Malenšek, Š., & Jerala, R. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.04.005 · Cited by 12
“NFAT plays a complex role in T cells; as the constitutively active NFAT can drive T cell anergy and exhaustion by upregulating genes for the inhibitory surface molecule expression, such as PD-1, LAG3, CTLA-4, and so on.(64,65) Despite that, we did not observe impaired IL2 secretion, which is also one of the hallmarks…”
BackgroundMüller, D. J., Wirths, S., Fuchs, A. R., Märklin, M., Heitmann, J. S., Sturm, M., Haap, M. M., Kirschniak, A., Sasaki, Y., Kanz, L., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ab0218-076rr · Cited by 12
Role of Nurr1 in Carcinogenesis and Tumor Immunology: A State of the Art Review
Wan, P. K.-T., Siu, M. K.-Y., Leung, T. H.-Y., Mo, X.-T., Chan, K. K. L., & Ngan, H. (2020) · Cancers · doi:10.3390/cancers12103044 · Cited by 12
“In addition, enrichment of the consensus binding motif for transcription factors associated with T cell activation i.e., NFAT: AP-1 composite site, and consensus binding motif for NFAT without an AP-1 site are observed.”
BackgroundInfluentialKwon, H., Kim, G.-C., Hwang, J. S., Kim, Y., Chae, C.-S., Nam, J. H., Jun, C., Rudra, D., Surh, C. D., & Im, S. (2016) · Scientific Reports · doi:10.1038/srep19453 · Cited by 12
Zhong, L., Wang, Y., Kahlfuß, S., Jishage, M., McDermott, M., Yang, J. J. J., Tao, A. Y., Hu, K., Noyer, L., Raphael, D., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02089-8 · Cited by 13
“We analyzed the binding of NFATc2 to the Tbx21 locus using ChIP–seq data from Nfatc2 −/− CD8 + T cells 34 and that of NFATc1 using ChIP–seq data from CD8 + T cells of a BAC-transgenic mouse strain in which NFATc1 is endogenously biotinylated by the biotin-ligase BirA 35 .”
T cell aging and exhaustion: Mechanisms and clinical implications
Zhang, W., Kong, D., Zhang, X., Hu, L., Nian, Y., & Shen, Z. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110486 · Cited by 13
CD8+ T cell-based immunotherapy: Promising frontier in human diseases
Ton, N. Q. C., Deka, G., & Park, P. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116909 · Cited by 12
NFAT1 Regulates Systemic Autoimmunity through the Modulation of a Dendritic Cell Property
Chae, C.-S., Kim, G.-C., Park, E. S., Lee, C., Verma, R. P., Cho, H., Jun, C., Yoo, Y. J., & Im, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700882 · Cited by 11
“haustion programs, depending on the nature of its binding partners (12).”
BackgroundIL-21 in Homeostasis of Resident Memory and Exhausted CD8 T Cells during Persistent Infection
Ren, H. M., & Lukacher, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186966 · Cited by 13
Chromatin-embedded reporter genes: Quantification of stimulus-induced gene transcription
Thiel, G., Backes, T. M., Guethlein, L. A., & Rößler, O. G. (2021) · Gene · doi:10.1016/j.gene.2021.145645 · Cited by 11
Vahedi, G. (2021) · Immunological Reviews · doi:10.1111/imr.12942 · Cited by 11
Slaats, J., Dieteren, C. E. J., Wagena, E., Wolf, L., Raaijmakers, T. K., van der Laak, J. A. W. M., Figdor, C. G., Weigelin, B., & Friedl, P. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0741 · Cited by 11
“NFAT is a critical transcriptional regulator of the CTL effector response, mediating T-cell proliferation and inhibitory checkpoint expression upon persistent antigenic stimulation (34, 35).”
BackgroundZhu, T., Teng, X., Jiao, Q., Ren, Y., Wang, Y., & Feng, M. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70609 · Cited by 12
“72 In this unopposed state, NFAT directly transactivates genes central to the exhaustion programme, including the IR PD-1 (via its Pdcd1 promoter) and the transcription factors NR4A and TOX.”
Immune Checkpoints in Solid Organ Transplantation
Bello, A. D., & Treiner, E. (2023) · Biology · doi:10.3390/biology12101358 · Cited by 10
“Similarly, NFAT promotes T cell exhaustion in CD8 T cells, suggesting that calcineurin inhibitors, which block NFAT translocation, can be harmful to exhaustion induction [123].”
BackgroundHELIOS-expressing human CD8 T cells exhibit limited effector functions
Neyens, D., Hirsch, T., Hadi, A. A. A. I. A., Dauguet, N., Vanhaver, C., Bayard, A., Wildmann, C., Luyckx, M., Squifflet, J.-L., D’Hondt, Q., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1308539 · Cited by 10
Xu, C., Wu, J., Ye, J., Si, Y., Zhang, J., Wu, B., Pan, L., Fu, J., Quan, R., Xie, S., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06840-1 · Cited by 13
“2J and S1F) [22].”
Metadata
- Authors
- Martinez, G. J., Pereira, R. M., Äijö, T., Kim, E. Y., Marangoni, F., Pipkin, M. E., Togher, S., Heissmeyer, V., Zhang, Y. C., Crotty, S., Lamperti, E. D., Ansel, K. M., Mempel, T. R., Lähdesmäki, H., Hogan, P. G., & Rao, A.
- Affiliations
- La Jolla Institute for Immunology (US)
- Harvard University (US)
- Scripps Research Institute (US)
- Helmholtz Munich (DE)
- St. Luke's-Roosevelt Hospital Center (US)
- Boston Children's Hospital (US)
- University of California, San Francisco (US)
- Aalto University (FI)
- Corresponding author
- Lähdesmäki, Harri
- Rao, Anjana
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 42
- Issue
- 2
- Pages
- 265-278
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC4346317
- OpenAlex
- W2018775174
- Cited by
- 857
- References
- 52
- Citations by year
- 2026: 104 · 2025: 97 · 2024: 110 · 2023: 104 · 2022: 84 · 2021: 95 · 2020: 84 · 2019: 69 · 2018: 30 · 2017: 37 · 2016: 26 · 2015: 17
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- National Cancer Institute (R01CA150975, U19CA179563, R01CA042471, R01 CA-42471)
- National Institute of Allergy and Infectious Diseases (R01 AI40127, R01AI072543, R01AI095634, AI84167, U19AI109976, R01AI084167, R01AI109842, R01AI040127)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- National Center for Research Resources (S10RR027366)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- NFAT1, T cell exhaustion, CD8+ T cells, T cell anergy, T cell receptor signaling, AP-1, inhibitory receptors, listeriosis, antitumor immunity, transcriptional regulation
- MeSH terms
- Animals, Cells, Cultured, Gene Expression Regulation, Listeriosis, Listeria monocytogenes, Lymphocyte Activation, Mice, Transgenic, Neoplasms, Promoter Regions, Genetic, Receptors, Antigen, T-Cell, Recombinant Proteins, Clonal Anergy, CD8-Positive T-Lymphocytes, Transcription Factor AP-1, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review